Bill > HR478

Introduced Session

To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada. This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.

AI Summary

Committee Categories

Chellie Pingree (D)*,  Ed Case (D),  Steve Cohen (D),  Angie Craig (D),  Lloyd Doggett (D),  John Garamendi (D),  Jared Golden (D),  Jaime Herrera Beutler (R),  Dave Joyce (R),  Ro Khanna (D),  Daniel Lipinski (D),  Max Rose (D),  Tim Ryan (D),  Elissa Slotkin (D),  Tom Tiffany (R),  Peter Welch (D), 

Referred to the Subcommittee on Health. (on 01/25/2019)

Official Document